Nagpur
+919405117673
+919405117673

Sunitinib Malate Capsules 12.5 mg Global Exporter | Cordium Pharmaceuticals Pvt Ltd

Cordium Pharmaceuticals Pvt Ltd is a trusted global pharmaceutical exporter from India, supplying high-quality oncology medicines including Sunitinib Malate Capsules 12.5 mg with fast and reliable international shipping. We ensure WHO-GMP certified manufacturing standards, safe packaging, and timely delivery to global markets including: ๐Ÿ‡บ๐Ÿ‡ธ United States | ๐Ÿ‡ฌ๐Ÿ‡ง United Kingdom | ๐Ÿ‡ฉ๐Ÿ‡ช Germany | ๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands | ๐Ÿ‡ฆ๐Ÿ‡ช United Arab Emirates | ๐Ÿ‡ฟ๐Ÿ‡ฆ South Africa | ๐Ÿ‡ง๐Ÿ‡ท Brazil ๐Ÿ’Š What is Sunitinib Malate Capsules 12.5 mg? Sunitinib Malate is an oral anti-cancer (tyrosine kinase inhibitor) medicine used in targeted cancer therapy. It helps slow or stop the growth of cancer cells by blocking specific proteins that promote tumor growth. ๐Ÿงช Uses / Indications Sunitinib Malate Capsules are commonly prescribed for: Renal Cell Carcinoma (Kidney Cancer) Gastrointestinal Stromal Tumors (GIST) Pancreatic Neuroendocrine Tumors Other solid tumors as prescribed by oncologists ๐Ÿ’Š Dosage Information Dosage is strictly based on doctorโ€™s prescription Common regimen: once daily oral capsule cycles (e.g., 4 weeks on / 2 weeks off) Should be taken at the same time each day with or without food Do not self-medicate or change dose without medical advice โš ๏ธ Possible Side Effects Some patients may experience: Fatigue or weakness Nausea, vomiting, diarrhea High blood pressure Skin discoloration or hand-foot syndrome Loss of appetite Mouth sores Liver function changes (rare but serious) ๐Ÿ‘‰ Always consult a healthcare professional if side effects persist. ๐ŸŒ Global Export & Supply Capability Cordium Pharmaceuticals Pvt Ltd ensures: Fast international shipping Secure export documentation Bulk & wholesale supply availability Hospital, distributor & pharmacy supply chain support ๐Ÿ“ž Contact Us for Global Orders ๐Ÿ“ฑ WhatsApp: +91-9405117673 ๐Ÿ“ง Email: info@cordiumpharma.com
 2026-04-18T06:57:56

Keywords